Seoulin Bioscience financial statements

서린바이오KRX:038070 · KOSDAQ · Healthcare · sector #23
₩4,115+0.49%
2026-10-07 close

Seoulin Bioscience's published financial data is dated 2026-10-04. 2024 revenue was KRW 75.41B. 2024 operating profit was KRW 101M.

Reported results

Seoulin Bioscience notifications

Quantus Signal · live data · not investment advice · Privacy Policy